Or Refractory Acute Myeloid Leukemia
📧 Sign up to get email alerts when something new happens for Or Refractory Acute Myeloid Leukemia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-11-18Clinical Trial Update: Clinical Trial of KK2845 in Patients With Relapsed or Refractory Acute Myeloid Leukemia [Phase 1]
Kyowa Kirin announced a Phase 1 clinical trial evaluating KK2845 in relapsed or refractory acute myeloid leukemia, and the study is currentl…
-
CLINICAL_TRIALS trial_result · 2025-10-07Clinical Trial Update: Pegcrisantaspase in Combination With Venetoclax for Treatment of Relapsed or Refractory Acute Myeloid Leukemia (R/R AML) [Phase 1]
Phase 1 trial evaluating pegcrisantaspase in combination with venetoclax for relapsed or refractory acute myeloid leukemia has completed.
-
CLINICAL_TRIALS trial_result · 2024-12-11Clinical Trial Update: A Study to Evaluate MK-0482 for Relapsed/Refractory Acute Myeloid Leukemia (AML) or Chronic Myelomonocytic Leukemia (CMML) (MK-0482-002) [Phase 1]
A Phase 1 study evaluating MK-0482 for relapsed or refractory acute myeloid leukemia and relapsed or refractory chronic myelomonocytic leuke…
-
CLINICAL_TRIALS trial_result · 2024-01-30Clinical Trial Update: Phase II Study of Crenolanib in Subjects With Relapsed/Refractory AML With FLT3 Activating Mutations [Phase 2]
Phase II study of crenolanib in relapsed or refractory AML with FLT3 activating mutations has completed; results posted.